Proangiogenic therapy as a treatment modality in the management of BRONJ
Sharma, Chakrabhavi Gundurao Dileep (2015) Proangiogenic therapy as a treatment modality in the management of BRONJ. In: Abstracts from 55th Annual Scientific Meeting of the IADR ANZ Division. 193641. pp. 102-103. From: 55th Annual Scientific Meeting of the IADR ANZ Division, 23-26 August 2015, Dunedin, New Zealand.
PDF (Abstract Only)
- Published Version
Restricted to Repository staff only |
Abstract
Objectives: Bisphosphonates (BPs) are known to have a direct effect on the local vasculature, but their effect on the differentiation of progenitor cells into endothelial cells, which may ultimately contribute to the pathogenesis of bisphosphonate- related osteonecrosisof the jaw (BRONJ), is unknown. This study evaluated both the in-vitro effect(s) of differing potency bisphosphonates on the differentiation of human placenta-derived mesenchymal stem cells (pMSCs) into an endothelial lineage and the in vivo effect of locally delivered VEGF on a healing extraction socket in a BRONJ rat model.
Item ID: | 70992 |
---|---|
Item Type: | Conference Item (Abstract / Summary) |
Keywords: | Hydrogel; Bisphosphonates; VEGF; Zoledronic acid |
Related URLs: | |
Date Deposited: | 01 Dec 2021 03:57 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3203 Dentistry > 320399 Dentistry not elsewhere classified @ 50% 32 BIOMEDICAL AND CLINICAL SCIENCES > 3203 Dentistry > 320303 Dental therapeutics, pharmacology and toxicology @ 50% |
SEO Codes: | 20 HEALTH > 2001 Clinical health > 200102 Efficacy of medications @ 100% |
Downloads: |
Total: 1 |
More Statistics |